Nisaurrahmah, Nisaurrahmah, et al. “Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review”. Journal of Drug Delivery and Therapeutics, vol. 11, no. 1-s, Feb. 2021, pp. 195-9, https://doi.org/10.22270/jddt.v11i1-s.4554.